AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, on Wednesday announced that it has received approval from the Drug Controller General of India (DCGI) for the cancer drug Trastuzumab Deruxtecan for the treatment of metastatic breast cancer.
New Delhi [India], July 12 (ANI): The Delhi High Court on Monday issued notice to National Pharmaceutical Pricing Authority (NPPA) and others on AstraZeneca Pharma India's petition challenging notice relating to Tagrisso 80 mg tablets.
Bangalore (Karnataka) [India], November 26 (ANI/PRNewswire): AstraZeneca India (AstraZeneca Pharma India Limited), a leading science-led biopharmaceutical company, today signed a memorandum of understanding with the Research Society for Study of Diabetes in India (RSSDI).
Mumbai (Maharashtra) [India], September 9 (ANI): Equity benchmark indices traded lower during early hours on Wednesday following losses in Asian markets after yesterday's rout in Wall Street.